Harvard Bioscience (NASDAQ:HBIO – Free Report) had its target price decreased by Benchmark from $3.00 to $2.00 in a report released on Wednesday morning,Benzinga reports. Benchmark currently has a speculative buy rating on the medical instruments supplier’s s…
UBS is said to weigh U.S. move amid Swiss capital rule dispute Read Full Article →
'Record of targeting conservatives' Read Full Article →
SBI and a group of private banks are poised to receive a tax exemption on ₹13,483 crore income from selling their stake in Yes Bank to SMBC. The Yes Bank Reconstruction Scheme, 2020, exempts banks from capital gains tax on profits from the share sale. This deal marks Japan&
Lyno AI is the first institutional-grade arbitrage technology available to retail investors using state-of-the-art AI algorithms. Unlike Etherum, Lyno AI is the best cryptocurrency presale in September 2025. Read Full Article →
Connect with us
